Arcus Biosciences, Inc. (RCUS) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $33.00M | -35.3% |
| 2024 | $51.00M | +37.8% |
| 2023 | $37.00M | -2.6% |
| 2022 | $38.00M | -90.1% |
| 2021 | $383.00M | +391.0% |
| 2020 | $78.00M | +420.0% |
| 2019 | $15.00M | +79.6% |
| 2018 | $8.35M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $33.00M | -35.3% |
| 2024 | $51.00M | +37.8% |
| 2023 | $37.00M | -2.6% |
| 2022 | $38.00M | -90.1% |
| 2021 | $383.00M | +391.0% |
| 2020 | $78.00M | +420.0% |
| 2019 | $15.00M | +79.6% |
| 2018 | $8.35M | — |